)
Edge28 Aug 2026
Bigger, Sharper, IMAX: A Blockbuster Business
How IMAX turned an unscalable, large-screen format into the center of blockbuster filmmaking through cameras, projection, and remastering technology.
Saniona
Saniona (SANION) investor relations material
Saniona Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary27 Aug, 2026
Executive summary
Internal development focus sharpened, prioritizing SAN2668 (pediatric epilepsy) and SAN2465 (major depressive disorder), both targeting Phase 1 trials by year-end 2026.
Partnered programs advanced, with Jazz Pharmaceuticals preparing SAN2355 for Phase 1 and Acadia Pharmaceuticals expanding ACP-711 Phase 1; milestone payments expected upon trial initiations.
AstronauTx exercised its option for ATX0926, resulting in a $5M share-based income and eligibility for up to $172M in milestones and royalties.
Strong cash position supports clinical advancement and ongoing collaborations.
Financial highlights
Q2 2026 revenue was SEK 4.5M (down from SEK 9.3M YoY); H1 2026 revenue SEK 9.2M (down from SEK 19.1M YoY).
Q2 operating loss widened to SEK -60.3M (from SEK -25.9M YoY); H1 operating loss SEK -116.8M (from SEK -42.4M YoY).
Net loss for Q2 was SEK -58.3M (from SEK -22.2M YoY); H1 net loss SEK -104.4M (from SEK -3.3M YoY).
Cash and cash equivalents at June 30, 2026: SEK 486.3M (up from SEK 308.2M YoY).
Basic and diluted EPS for H1: SEK -0.76 (from SEK -0.03 YoY).
Outlook and guidance
SAN2668 and SAN2465 prioritized for clinical entry by year-end 2026.
Continued focus on advancing partnered programs and maintaining financial discipline.
Ambition to partner at least one internal asset in the near to midterm.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Saniona
- SAN2668 advances for pediatric epilepsies with strong efficacy, safety, and strategic partnerships.SANION
R&D Day 2026 - Advancing three CNS drug candidates to phase I by early 2025, backed by robust cash and partnerships.SANIONAktiedagarna 2026
- Differentiated CNS pipeline and strong partnerships drive value in epilepsy and depression.SANIONCorporate presentation
- Losses widened on lower revenue and higher R&D, but cash reserves and pipeline progress remain strong.SANIONQ1 2026
- Advancing three selective GABA modulators for CNS disorders, backed by major pharma partnerships.SANIONCorporate presentation
- Strong partnerships and pipeline progress drive growth, with key milestones expected soon.SANIONLife Science Conference 2026
- Advancing three CNS programs with robust funding and strategic partnerships for clinical milestones.SANIONLife Science-dagen 2026
- Full-year revenue and profit soared on partnership deals, with a robust pipeline set for clinical progress.SANIONQ4 2025
- Advancing key programs and partnerships, with Tesofensine approval and new milestones expected.SANIONStatus Update
Next Saniona earnings date
Q3 202626 Nov, 2026
Saniona
Next Saniona earnings date
Q3 202626 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage